ABBV - AbbVie Inc. Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (0.21%) DNN (%) AGRX (-1.54%) NVAX (%) PTON (-0.16%) AAPL (%) MOMO (%) LOW (-0.15%) LEDS (%) LAKE (%) JPM (%) JNJ (%) JMIA (%) JEF (1.28%) INTC (%) GPRO (%) FDX (%) FB (%) ENDP (%) ELOX (%) CVX (%) CVM (-1.98%) CMCSA (%) BTCUSD (%) BABA (%)

ABBV - AbbVie Inc.

$83.26 -0.51[-0.61%]

15 mins delayed data

People also watch : LLY | AZN | BIIB | NBIX | BMY | PFE

+Watchlist

12 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$83.77	Open	$83.80
Volume	4.11M	Market Cap	124.25B
Yield	5.09 %	Last Dividend	$4.28

Day

52 Week

February Market Outlook: Coronavirus, D....	2:53 PM
If you???ve raised kids, you???re probably familiar with the expression, ???The odd years are even and the even years are odd.??? Well, that???s also ...

AbbVie : Statement on Coronavirus and lo...	01/28/20
The Chinese health authorities have requested supply of Aluvia as part of the government's broader efforts to address the coronavirus crisis in China....

Nestl?? aids Allergan deal	01/27/20
US drugmaker AbbVie???s $63bn (???57bn) tie-up with Allergan is getting help from Nestl?? and AstraZeneca buying up products the Irish-domiciled compa...

Trading AbbVie as Its Drug Is Seen as Po...	01/27/20
AbbVie is rallying Monday as the company divests assets to get approval for its Allergan deal and as the company tries to help treat the coronavirus.

Why AbbVie Looks Like a Bargain at These...	01/27/20
Why AbbVie Is a Bargain at These Levels???ABBV

AbbVie-Allergan US$63 billion deal aided...	01/27/20
U.S. drugmaker AbbVie's US$63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company ...

AbbVie-Allergan $63 billion deal aided b...	01/27/20
https://www.investing.com/news/stock-market-news/abbvieallergan-63-billion-deal-aided-by-nestle-astrazeneca-buys-2068141

Nestle kauft Magen-Darm-Medikament von A...	01/27/20
Der Schweizer Lebensmittelkonzern Nestle baut sein Medizin-Gesch??ft aus. Der Schweizer Lebensmittelkonzern Nestle baut sein Medizin-Gesch??ft mit ein...

China testa medicamento contra HIV para ...	01/26/20
(Reuters) - A China est?? testando um medicamento contra o HIV como tratamento para os sintomas do novo coronav??rus que est?? se espalhando rapidamen...

Better Buy: AbbVie vs. Johnson & Johnson...	01/24/20
Both of these pharma companies have had troubles of late, but which one will outperform the other from here on out?

ANALYST RATINGS

6 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	12/26/19
Cowen & Co. maintains Outperform rating and raises Price Target from $90.00 to $98.00

Buy rating	11/20/19
Citi maintains Buy rating and raises Price Target from $90.00 to $98.00

Buy rating	11/19/19
UBS maintains Buy rating and raises Price Target from $79.00 to $96.00

Buy rating	09/12/19
UBS upgrades from Neutral to Buy rating and lowers Price Target from $85.00 to $79.00

Strong Buy rating	09/04/19
Piper Jaffray maintains Overweight rating and raises Price Target from $80.00 to $81.00

Strong Buy rating	08/20/19
Piper Jaffray upgrades from Neutral to Overweight rating and announces Price Target of $80.00

EARNINGS

Date	2019-11-01 (BMO)	Est. (EPS/Rev.)	$2.30/ 8.38B
Actual (EPS/Rev.)	$2.33/ $8.48 B	EPS (TTM)	2.18

TRADERS TRACKING $ABBV

Service Name	Trader	% Success
OptionIncome	random motion	95.00 %	Subscribe
Alpha Swing Trades	Jonathan	69.00 %	Follow
Rocket Investing	Waqas	66.00 %	Subscribe
Growth Safe Bets	Hao	61.00 %	Subscribe
MA MA MIA	Hao	60.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.